We are currently investigating a rodent study by using apolipoprotein E-knockout (apoE KO) mice as our mice model to induce atherosclerosis and identify the role of the LPL inhibitor NDGA on CVD risk and HDL subpopulations. This evidence concerns the gene APOE and atherosclerosis.